Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binkui Li

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 25, 2024
m<sup>6</sup>A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinomaZhu Lin, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2023
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrenceChenwei Wang, Kai Li, Zhenkun Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After SurgeryWei He, Baogang Peng, Yunqiang Tang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2024
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapyShaoru Liu, Zongfeng Wu, Chenwei Wang, et al.
Cancer Communications (London, England)|August 15, 2018
Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4Liru He, Haixia Deng, Shiliang Liu, et al.
Cancer Cell International|April 16, 2024
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinomaYunxing Shi, Kai Li, Yichuan Yuan, et al.
The American Surgeon|July 4, 2019
Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma PatientsYuanping Zhang, Pinzhu Huang, Yun Zheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2016
Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysisWei He, Binkui Li, Yun Zheng, et al.
Med (New York, N.Y.)|May 7, 2026
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trialJiliang Qiu, Zhenkun Huang, Wei He, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 29, 2024
Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastasesHuiFang Li, Ming Shi, Xingzhang Long, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|July 25, 2024
m<sup>6</sup>A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinomaZhu Lin, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2023
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrenceChenwei Wang, Kai Li, Zhenkun Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After SurgeryWei He, Baogang Peng, Yunqiang Tang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2024
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapyShaoru Liu, Zongfeng Wu, Chenwei Wang, et al.
Cancer Communications (London, England)|August 15, 2018
Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4Liru He, Haixia Deng, Shiliang Liu, et al.
Cancer Cell International|April 16, 2024
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinomaYunxing Shi, Kai Li, Yichuan Yuan, et al.
The American Surgeon|July 4, 2019
Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma PatientsYuanping Zhang, Pinzhu Huang, Yun Zheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2016
Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysisWei He, Binkui Li, Yun Zheng, et al.
Med (New York, N.Y.)|May 7, 2026
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trialJiliang Qiu, Zhenkun Huang, Wei He, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 29, 2024
Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastasesHuiFang Li, Ming Shi, Xingzhang Long, et al.
Pageof 9